A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)

NCT07145151 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolic Dysfunction-associated Steatohepatitis (MASH)

Interventions

DRUG: UBT251
DRUG: Placebo

Sponsor

The United Bio-Technology (Hengqin) Co., Ltd.